Skip to content
  • Diet & Nutrition
  • Lifestyle & Wellbeing
  • News & Research
  • Treatment & Management
  • Patient Narratives
  • Glycaemic Index
  • Carbohydrate Counting
Quest Diabetes
Quest Diabetes
  • Diet & Nutrition
  • Lifestyle & Wellbeing
  • News & Research
  • Treatment & Management
  • Patient Narratives
  • Glycaemic Index
  • Carbohydrate Counting
Quest Diabetes
  • Lifestyle & Wellbeing

Maintaining a normal BMI in youth linked to lower risk of type 1 diabetes progression

A new study finds that children and adolescents who shift from overweight to a normal body-mass index may significantly reduce their risk of developing clinical type 1 diabetes, highlighting the potential impact of lifestyle factors in early disease management. A…

  • apxadmin
  • August 20, 2026
  • News & Research

FDA proposal to restrict compounded GLP-1 medicines raises safety concerns for pharmacists

Pharmacists express heightened concerns over the safety, authenticity, and regulation of compounded GLP-1 medicines as the FDA moves towards tighter rules amid rising demand and market complexities. Pharmacists are increasingly being asked to help patients navigate a fast-changing market for…

  • apxadmin
  • August 20, 2026
  • Lifestyle & Wellbeing

Isha Yoga practices show promising mental health benefits in 2026 systematic review

A 2026 review of controlled studies suggests that Isha Yoga may significantly reduce stress, anxiety, and depression while enhancing overall well-being, with benefits more pronounced in regular practitioners. Yoga may do more than improve flexibility. A 2026 systematic review of…

  • apxadmin
  • August 20, 2026
  • News & Research

Greenstone Biosciences secures breakthrough funding to advance type 1 diabetes research using organoid technology

Greenstone Biosciences has received funding from Breakthrough T1D to develop a pioneering research platform using induced pluripotent stem cells and organoids, aiming to uncover why insulin-producing beta cells become vulnerable in type 1 diabetes. Greenstone Biosciences has won funding from…

  • apxadmin
  • August 20, 2026
  • Treatment & Management

NHS on brink of approving weekly insulin pen to ease diabetes management

A new weekly insulin pen for type 2 diabetes is close to NHS approval, promising to dramatically reduce daily injections and improve treatment adherence for vulnerable patients, with potential to reshape diabetes care routines. A once-weekly insulin pen for type…

  • apxadmin
  • August 20, 2026
  • News & Research

Metformin's potential as an anti-ageing drug remains uncertain amid mixed evidence

Researchers continue to explore metformin as a possible drug to slow certain aspects of ageing, but evidence supporting its effectiveness remains inconsistent. While it influences various ageing pathways, its role in extending healthspan or lifespan in humans is still unproven,…

  • apxadmin
  • August 20, 2026
  • Glycaemic Index

Guar gum enhances nutritional profile of hydrothermally treated rice by reducing glycaemic response

A recent study reveals that applying guar gum to hydrothermally treated rice optimises digestion and visual integrity, offering a promising avenue for healthier rice options with lower glycaemic impact. Hydrocolloids can do more than alter rice texture; they can also…

  • apxadmin
  • August 20, 2026
  • Lifestyle & Wellbeing

Multiple nights of sleep restriction are linked to increased inflammation, not a single bad night

Emerging evidence suggests that while one poor night of sleep has little effect on inflammation markers, sustained sleep restriction over several nights significantly elevates inflammatory responses, highlighting the importance of consistent sleep patterns for health. The link between sleep and…

  • apxadmin
  • August 20, 2026
  • News & Research

Wider use of GLP-1 drugs reveals unexpected health benefits and risks beyond weight loss

As millions take newer dual-action obesity drugs, emerging research uncovers promising benefits like reduced inflammation and cardiovascular risks, alongside concerns over muscle loss and nutrient deficiencies, prompting calls for further targeted studies. Millions of people are now taking GLP-1 receptor…

  • apxadmin
  • August 20, 2026
  • Lifestyle & Wellbeing

Brief all-out sprints trigger rapid and extensive molecular responses more effectively than longer moderate sessions

A new study reveals that just 30 seconds of high-intensity sprinting can provoke significantly greater cellular and metabolic reactions than extended moderate exercise, potentially reshaping fitness strategies. A short burst of all-out exercise may trigger a much larger and faster…

  • apxadmin
  • August 20, 2026
Prev
1 … 149 150 151 152 153 154 155 … 200
Next

Search

No results

Posts

Type 1 diabetes cases expected to rise sharply worldwide by 2049

September 10, 2026

Toronto health fair spotlights innovative community-led approaches to diabetes prevention in Afro-Caribbean populations

September 18, 2026

Study suggests fluctuating blood sugar levels may boost next-day wellbeing in people with diabetes

September 26, 2026

Six decades on, Políbio Braga remains a force in Brazil’s political journalism

October 13, 2026

Oneness Biotech progresses SNS851 to phase 1 trial targeting fatty liver disease

September 29, 2026

Trending now

Bamboo extract dampens diabetes-linked cell stress in rats, study finds
New guidelines help people with diabetes enjoy summer cookouts without guilt
Gestational diabetes alters early brain response to food cues during pregnancy
Personal glucose pattern analyser offers targeted insights for diabetes management

Copyright © 2026 - QuestDiabetes.com

Disclaimer | Terms & Conditions | Privacy Policy